FDA's Behind-the-Counter Drug Plan Riles Docs The Food and Drug Administration is considering creating a new class of drugs that would sit on shelves behind the register, and pharmacists could help people decide whether the drugs are right for them. But some doctors say pharmacists don't have the qualifications to give out medical advice.
NPR logo

FDA's Behind-the-Counter Drug Plan Riles Docs

  • Download
  • <iframe src="https://www.npr.org/player/embed/16630779/16630751" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
FDA's Behind-the-Counter Drug Plan Riles Docs

FDA's Behind-the-Counter Drug Plan Riles Docs

FDA's Behind-the-Counter Drug Plan Riles Docs

  • Download
  • <iframe src="https://www.npr.org/player/embed/16630779/16630751" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The Food and Drug Administration is considering creating a new category for drugs — a class that would sit on shelves behind the register.

These would be drugs that need to be used carefully but aren't complicated enough to require a prescription. The idea is that pharmacists could help people decide whether these drugs are right for them.

Some doctors are opposed to the plan, saying pharmacists don't have all of the qualifications needed to give out medical advice.